Observational studyBMC ophthalmology2025
Efficacy of mini-scleral lenses in visual rehabilitation for corneal disorders: a prospective study.
Observational study in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of a three-month period of mini-scleral lens usage on intraocular pressure and the anterior chamber angle in patients with keratoconus.International journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCorneal irregularities are a significant cause of visual impairment, impacting patients' quality of life. Conventional treatment with spectacles and/or contact lenses fail to provide adequate rehabilitation in these cases. This study aimed to evaluate the efficacy and patient satisfaction with use of mini-scleral devices (MSDs) in patients with various corneal disorders including keratoconus, corneal scarring, post-corneal transplant, and post-refractive surgery.
methodsThis analytical, observational, prospective study included 40 eyes of 32 patients with corneal surface irregularities and rigid gas permeable (RGP) or soft contact lenses intolerance. Comprehensive ophthalmic evaluation, including corneal topography, was performed. Primary outcomes measured were improvement in best lens-corrected visual acuity (BLCVA) by ≥ 2 lines and daily wear time of ≥ 10 h. Secondary outcomes included patient comfort, lens acceptance, and adverse events. Patients were followed up for a duration of three months.
resultsMSDs significantly improved visual outcomes, with 80% of eyes achieving a BLCVA of ≥ 0.4 logMAR. Patients with keratoconus (85%) and post-refractive surgery status (100%) exhibited best visual improvement. The mean daily wear time was 12.1 ± 2.2 h. High comfort levels were reported in 26 eyes, while 12.5% of patients discontinued using the MSDs. No significant adverse events were observed.
conclusionMSDs represent a valuable therapeutic option offering improved visual outcomes, high levels of patient satisfaction and comfort in patients with various corneal disorders. These are a good alternative for eyes not amenable to correction with glasses or contact lenses, especially in patients planned for or awaiting corneal transplant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.